Copyright Reports & Markets. All rights reserved.

Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Paracetamol
    • 1.4.3 Ibuprofen
    • 1.4.4 Aspirin
    • 1.4.5 Naproxen
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital Pharmacies
    • 1.5.3 Retail Pharmacies
    • 1.5.4 Online Pharmacies
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2015-2026)
  • 2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions
    • 2.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Share by Regions (2015-2020)
    • 2.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Market Size
    • 3.1.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2015-2020)
    • 3.1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
    • 3.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2019
  • 3.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
  • 3.4 Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
  • 3.5 Date of Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2015-2020)
  • 4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)
  • 5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
  • 6.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in North America (2019-2020)
  • 6.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
  • 6.4 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
  • 7.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Europe (2019-2020)
  • 7.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
  • 7.4 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

8 China

  • 8.1 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
  • 8.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in China (2019-2020)
  • 8.3 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
  • 8.4 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
  • 9.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Japan (2019-2020)
  • 9.3 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
  • 9.4 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
  • 10.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

11 India

  • 11.1 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
  • 11.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in India (2019-2020)
  • 11.3 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
  • 11.4 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2015-2020)
  • 12.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2015-2020)
  • 12.4 Central & South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Novartis
    • 13.1.1 Novartis Company Details
    • 13.1.2 Novartis Business Overview
    • 13.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
    • 13.1.4 Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020))
    • 13.1.5 Novartis Recent Development
  • 13.2 Pfizer
    • 13.2.1 Pfizer Company Details
    • 13.2.2 Pfizer Business Overview
    • 13.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
    • 13.2.4 Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
    • 13.2.5 Pfizer Recent Development
  • 13.3 Boehringer Ingelheim
    • 13.3.1 Boehringer Ingelheim Company Details
    • 13.3.2 Boehringer Ingelheim Business Overview
    • 13.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
    • 13.3.4 Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
    • 13.3.5 Boehringer Ingelheim Recent Development
  • 13.4 Teva Pharmaceutical
    • 13.4.1 Teva Pharmaceutical Company Details
    • 13.4.2 Teva Pharmaceutical Business Overview
    • 13.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
    • 13.4.4 Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
    • 13.4.5 Teva Pharmaceutical Recent Development
  • 13.5 Hospira
    • 13.5.1 Hospira Company Details
    • 13.5.2 Hospira Business Overview
    • 13.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
    • 13.5.4 Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
    • 13.5.5 Hospira Recent Development
  • 13.6 Lonza Group
    • 13.6.1 Lonza Group Company Details
    • 13.6.2 Lonza Group Business Overview
    • 13.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
    • 13.6.4 Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
    • 13.6.5 Lonza Group Recent Development
  • 13.7 Mylan
    • 13.7.1 Mylan Company Details
    • 13.7.2 Mylan Business Overview
    • 13.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
    • 13.7.4 Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
    • 13.7.5 Mylan Recent Development
  • 13.8 Aurobindo Pharma
    • 13.8.1 Aurobindo Pharma Company Details
    • 13.8.2 Aurobindo Pharma Business Overview
    • 13.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
    • 13.8.4 Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
    • 13.8.5 Aurobindo Pharma Recent Development
  • 13.9 Dr. Reddy's Laboratories
    • 13.9.1 Dr. Reddy's Laboratories Company Details
    • 13.9.2 Dr. Reddy's Laboratories Business Overview
    • 13.9.3 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
    • 13.9.4 Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
    • 13.9.5 Dr. Reddy's Laboratories Recent Development
  • 13.10 Actavis
    • 13.10.1 Actavis Company Details
    • 13.10.2 Actavis Business Overview
    • 13.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
    • 13.10.4 Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
    • 13.10.5 Actavis Recent Development
  • 13.11 Wuxi Apptec
    • 10.11.1 Wuxi Apptec Company Details
    • 10.11.2 Wuxi Apptec Business Overview
    • 10.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
    • 10.11.4 Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
    • 10.11.5 Wuxi Apptec Recent Development
  • 13.12 Zhejiang NHU
    • 10.12.1 Zhejiang NHU Company Details
    • 10.12.2 Zhejiang NHU Business Overview
    • 10.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
    • 10.12.4 Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2015-2020)
    • 10.12.5 Zhejiang NHU Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Novartis
    Pfizer
    Boehringer Ingelheim
    Teva Pharmaceutical
    Hospira
    Lonza Group
    Mylan
    Aurobindo Pharma
    Dr. Reddy's Laboratories
    Actavis
    Wuxi Apptec
    Zhejiang NHU

    Market segment by Type, the product can be split into
    Paracetamol
    Ibuprofen
    Aspirin
    Naproxen
    Others
    Market segment by Application, split into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now